Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma

[This corrects the article DOI: 10.3389/fonc.2020.01378.].

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2021-12, Vol.11, p.817747-817747
Main Authors: Liu, Hailiang, Xu, Yong, Liang, Kai, Liu, Rong
Format: Article
Language:English
Subjects:
3,4-methylenedioxy-b-nitrostyrene
cytokine-induced killer cells
immunotherapy
NLRP3 inflammasome
Oncology
pancreatic ductal adenocarcinoma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[This corrects the article DOI: 10.3389/fonc.2020.01378.].
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.817747